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coBACKGROUND Aortic valve calciﬁcation (AVC) load measures lesion severity in aortic stenosis (AS) and is useful for
diagnostic purposes. Whether AVC predicts survival after diagnosis, independent of clinical and Doppler echocardio-
graphic AS characteristics, has not been studied.
OBJECTIVES This study evaluated the impact of AVC load, absolute and relative to aortic annulus size (AVCdensity), on
overall mortality in patients with AS under conservative treatment and without regard to treatment.
METHODS In 3 academic centers, we enrolled 794 patients (mean age, 73  12 years; 274 women) diagnosed with AS by
Doppler echocardiography who underwent multidetector computed tomography (MDCT) within the same episode of
care. Absolute AVC load and AVCdensity (ratio of absolute AVC to cross-sectional area of aortic annulus) were measured,
and severe AVC was separately deﬁned in men and women.
RESULTS During follow-up, there were 440 aortic valve implantations (AVIs) and 194 deaths (115 under medical
treatment). Univariate analysis showed strong association of absolute AVC and AVCdensity with survival (both, p < 0.0001)
with a spline curve analysis pattern of threshold and plateau of risk. After adjustment for age, sex, coronary artery
disease, diabetes, symptoms, AS severity on hemodynamic assessment, and LV ejection fraction, severe absolute AVC
(adjusted hazard ratio [HR]: 1.75; 95% conﬁdence interval [CI]: 1.04 to 2.92; p ¼ 0.03) or severe AVCdensity (adjusted HR:
2.44; 95% CI: 1.37 to 4.37; p ¼ 0.002) independently predicted mortality under medical treatment, with additive model
predictive value (all, p # 0.04) and a net reclassiﬁcation index of 12.5% (p ¼ 0.04). Severe absolute AVC (adjusted HR:
1.71; 95% CI: 1.12 to 2.62; p ¼ 0.01) and severe AVCdensity (adjusted HR: 2.22; 95% CI: 1.40 to 3.52; p ¼ 0.001) also
independently predicted overall mortality, even with adjustment for time-dependent AVI.
CONCLUSIONS This large-scale, multicenter outcomes study of quantitative Doppler echocardiographic and MDCT
assessment of AS shows that measuring AVC load provides incremental prognostic value for survival beyond clinical and
Doppler echocardiographic assessment. Severe AVC independently predicts excess mortality after AS diagnosis, which is
greatly alleviated by AVI. Thus, measurement of AVC by MDCT should be considered for not only diagnostic but also
risk-stratiﬁcation purposes in patients with AS. (J Am Coll Cardiol 2014;64:1202–13) © 2014 by the American College of
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AB BR E V I A T I O N S
AND ACRONYM S
AS = aortic stenosis
AU = arbitrary unit(s)
AVA = aortic valve area
AVC = aortic valve calciﬁcation
AVI = aortic valve implantation
CAD = coronary artery disease
HF = heart failure
LV = left ventricular
MDCT = multidetector
computed tomography
MG = mean gradient
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1203C alciﬁc aortic stenosis (AS) occurs frequently,and aortic valve implantation (AVI), surgicalor percutaneous, is the only effective treat-
ment (1,2). According to U.S. and European guide-
lines, AVI is indicated in severe symptomatic AS
(1,2) on the basis of classic studies showing poor out-
comes after symptom onset (3,4). However, in recent
decades, AS etiology has fundamentally evolved to
become predominantly “degenerative” (5). Thus,
nowadays, AS affects elderly patients, in whom the
evaluation and interpretation of symptoms and even
the interpretation of valvular hemodynamic data
can be puzzling (6), requiring other objective markers
of diagnosis and risk.SEE PAGE 1214 NRI = net reclassiﬁcation indexBecause valvular calciﬁcation is the intrinsic
mechanism leading to AS development, and because
it can be accurately measured by computed tomog-
raphy (CT) (7), aortic valve calciﬁcation (AVC) load
assessment generates considerable interest. In the
general population, screening studies (8) and a meta-
analysis of data from smaller series (9) suggest that
AVC qualitative assessment may be of prognostic
importance. More speciﬁcally, in patients with AS,
physiological studies advance that because AVC
quantiﬁcation is strongly but nonlinearly (7) associ-
ated with hemodynamic measures of AS severity, it
may add incremental value to Doppler echocardiog-
raphy. We gained improved interpretation of quanti-
ﬁed AVC load with the demonstration that the
association between AVC and hemodynamic data is
robust but different in men and women (10), leading
to sex-speciﬁc thresholds for deﬁning severe AVC
compared with Doppler echocardiographic hemody-
namic AS severity (11).
Although the physiological and diagnostic values
of AVC in AS are now better supported, particularly in
patients with discordant gradients (11), the impact on
survival of AVC load, as measured by multidetector
computed tomography (MDCT) after AS diagnosis,
remains undeﬁned. Initial qualitative studies using
echocardiography were encouraging (12,13) but
remain isolated. Pilot CT studies suggested that
AVC load may be linked to cardiovascular events,
particularly AVI indications, but with inconsistentfrom the International Chair of Cardiometabolic Risk, Quebec, Quebec, Can
Edwards Lifesciences; and has served on the advisory board of Medtronic, In
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These pilot studies generated potential clin-
ical interest and the hypothesis that in pa-
tients with AS, AVC load may be a
determinant of survival after diagnosis as a
major and categorically deﬁnable endpoint,
independent of and incremental to valvular
hemodynamic data obtained by Doppler
echocardiography. The present study took
advantage of the large patient volume of our
multicenter international registry of calciﬁed
aortic valve diseases to evaluate the impact of
quantitatively deﬁned AVC load, absolute
and relative to left ventricular (LV) outﬂow
tract size (AVCdensity), on overall mortality in
patients under conservative treatment. This
study’s secondary aim was to evaluate the impact
of AVC on overall survival regardless of treatment.METHODS
We prospectively recruited 794 adult patients
with at least mild AS (deﬁned as a mean gradient
[MG] $15 mm Hg, peak aortic jet velocity
[Vmax] $2.0 m/s, or aortic valve area [AVA] #2 cm2)
who underwent comprehensive Doppler echocardi-
ography and MDCT within the same episode of care
(<3 months between evaluations) at 1 of 3 academic
centers: the Mayo Clinic (Rochester, Minnesota),
Bichat Hospital (Paris, France), or the University
Institute of Cardiology and Pneumology (IUCPQ)
(Quebec, Quebec, Canada). We excluded patients
age <18 years and those with identiﬁed rheumatic
valve disease or endocarditis, congenital heart
disease (except bicuspid aortic valve), moderate or
severe aortic regurgitation or mitral valve disease,
and/or a history of valve repair or implantation.
Informed consent was obtained according to approval
by each institutional review board.
DOPPLER ECHOCARDIOGRAPHY MEASUREMENTS.
Doppler echocardiographic data were obtained
according to recommendations of echocardiographic
societies (15), and included left ventricular (LV)
dimensions and ejection fraction, Vmax, MG by
modiﬁed Bernoulli formula, stroke volume measuredada. Dr. Vahanian has received an honorarium from
c. All other authors have reported that they have no
ntin Fuster.
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14, accepted May 26, 2014.
TABLE 1 Baseline Cl
Clinical data
Age, yrs
Female
Body mass index, kg
Body surface area, m
Systolic blood pressu
mm Hg
Diastolic blood press
mm Hg
Heart rate, beat/min
Heart failure sympto
Hypertension
Coronary artery dise
Diabetes
Hyperlipidemia
Previous CABG
Echocardiographic data
Peak aortic jet veloc
Mean gradient, mm
Aortic valve area, cm
AVAi, cm2/m2
LV outﬂow tract
diameter, cm
LV ejection fraction,
LV mass index, g/m2
MDCT data
Aortic valve calciﬁca
Men
Women
AVCdensity, AU/cm
2
Men
Women
Coronary artery calci
load,‡ AU
Values are mean  SD, n (
AU/cm2 in men. †Deﬁned
635 patients.
AU ¼ arbitrary unit(s);
AVC ¼ aortic valve calc
MDCT ¼ multidetector com
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1204in the LV outﬂow tract, and AVA, calculated using the
continuity equation as absolute AVA or indexed to
body surface area (AVAi).
MDCT MEASUREMENTS. Noncontrast CT was per-
formed using multidetector scanners (Sensation
or Somatom, Siemens AG Healthcare, Erlangen,
Germany; MX 8000 IDT 16, Philips Healthcare, And-
over, Massachusetts). The 3 centers used the same
methodology of image acquisition and interpretation,
which was previously described (11,16). AVC mea-
surements were performed off-line on dedicatedinical, Echocardiographic, and MDCT Characteristics
Study Groups
All Patients
(N ¼ 794)
Nonsevere
AVCdensity*
(n ¼ 384)
Severe
AVCdensity†
(n ¼ 410) p Value
70  13 76  11 <0.0001 73  12
122 (32) 152 (37) 0.12 274 (35)
/m2 28.2  5.4 28.4  6.5 0.69 28.3  5.9
2 1.90  0.23 1.91  0.25 0.46 1.90  0.24
re, 131  18 127  19 0.01 129  19
ure, 72  11 70  11 0.11 71  11
66  13 69  13 0.001 68  13
ms 51 (13) 160 (39) <0.0001 211 (27)
266 (69) 278 (68) 0.66 544 (69)
ase 153 (40) 194 (47) 0.04 347 (44)
82 (21) 98 (24) 0.38 180 (23)
265 (69) 269 (66) 0.30 534 (67)
81 (21) 102 (25) 0.23 183 (23)
ity, m/s 3.0  0.7 4.4  0.8 <0.0001 3.7  1.0
Hg 22  11 47  17 <0.0001 35  19
2 1.34  0.39 0.87  0.21 <0.0001 1.10  0.39
0.71  0.20 0.46  0.11 <0.0001 0.58  0.20
2.25  0.20 2.22  0.22 0.10 2.23  0.21
% 62  10 58  14 <0.0001 60  12
108  26 127  37 <0.0001 118  33
tion, AU
1,070
(575–1,531)
3,403
(2,662–4,458)
<0.0001 2,022
(1,042–3,397)
436
(211–782)
1,879
(1,355–2,774)
<0.0001 1,103
(495–2,028)
257 (136–364) 790 (630–1,011) <0.0001 473 (256–789)
127 (58–215) 553 (401–819) <0.0001 318 (142–593)
um 362 (39–1,199) 920 (235–2,322) <0.0001 719 (107–1,916)
%), or median (interquartile range). *Deﬁned as <292 AU/cm2 in women and <476
as $292 AU/cm2 in women and $476 AU/cm2 in men. ‡Measurable in a subset of
AVA ¼ aortic valve area; AVAi ¼ aortic valve area indexed to body surface area;
iﬁcation; CABG ¼ coronary artery bypass graft surgery; LV ¼ left ventricular;
puted tomography.workstations using validated software (HeartBeat
CS [Philips Healthcare] or Aquarius iNtuition [Tera-
Recon, Inc., Foster City, California]) by the Agatston
method (17) and expressed in arbitrary units (AU).
We previously showed that AVC values of $1,274
AU in women and $2,065 AU in men were the best
cutoff values to deﬁne severe AVC according to
Doppler echocardiographic evaluation of AS (11).
Moreover, to account for interindividual variability in
body size, we showed that indexing AVC to the cross-
sectional area of the aortic annulus was the preferable
indexation and that the best thresholds for AVCdensity
were 292 and 476 AU/cm2 in women and men,
respectively (11). Thus, we dichotomized AVC and
AVCdensity in severe and nonsevere calciﬁcation using
these previously deﬁned thresholds.
In a subset of 635 patients, the entire heart was
visible on MDCT scanning; coronary artery calcium
load was calculated and considered severe when
greater than the median value in our population.
Technologists and cardiologists performing CT
acquisitions and measurements were kept blinded
to the clinical, Doppler echocardiographic, and
outcomes data. The median time between Doppler
echocardiography and MDCT was 1 day (interquartile
range: 0 to 9 days).
SYMPTOM STATUS. Patients were considered symp-
tomatic if they presented with dyspnea, New York
Heart Association functional class III or IV, angina
(Canadian Cardiovascular Society class III or IV), pre-
syncope, or syncope. Among patients considered
asymptomatic, some had minor symptoms (dyspnea
or angina with vigorous physical activity).
STUDY ENDPOINTS. The primary endpoint was
overall survival under medical treatment. Hence in
patients who underwent AVI, the AVI date was
used to compute the duration of follow-up under
medical management, but AVI was not an endpoint.
Secondary endpoints were cardiovascular death
under medical management and the overall and
cardiovascular survival during the entire follow-
up, regardless of AVI status. Outcomes data were
obtained from patient visits or records, mailed
questionnaires, or scripted telephone interviews
with patients or physicians, and death certiﬁcates
when applicable. Follow-up to death, AVI, or $5 years
post-diagnosis was completed in 762 patients (96%).
STATISTICAL ANALYSIS. Results are expressed as
mean  SD, median (interquartile range), or per-
centages when appropriate. Continuous variables
were tested for normality by the Shapiro-Wilk test.
AVC, AVCdensity, and coronary artery calcium load
were not normally distributed. We used a square-root
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FIGURE 1 Impact of AVC Burden on Mortality in Patients With AS, by Sex
Spline curve analysis of absolute aortic valve calciﬁcation (AVC) (A and B) and AVCdensity
(ratio of absolute AVC index to cross-sectional area of aortic annulus) (C and D), in women
(A and C) and in men (B and D) with aortic stenosis (AS). The spline curve (solid lines) is
presented with 95% conﬁdence interval (dotted lines). The x-axis represents the AVC
load; the y-axis, the relative risk (RR) for mortality. The horizontal line at RR ¼ 1 represents
the mean risk in the cohort. The grey zone represents the range of AVC loads corre-
sponding to the 95% bracket of the spline curve when it crosses the line at RR ¼ 1.
AU ¼ arbitrary unit(s).
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1205transformation to normalize AVC and AVCdensity, and
all analysis of AVC or AVCdensity as continuous vari-
ables used square-root–transformed levels that well-
normalized distributions, with a W-statistic of
Shapiro-Wilk test of $0.997 and p $ 0.08.
Differences between patients with nonsevere or
severe AVCdensity were analyzed using the Student t
test for continuous normally distributed variables,
the Wilcoxon rank sum test for continuous non–
normally distributed variables, and the chi-square
test for nominal variables.
Differences of classiﬁcation between graphically
determined thresholds and previously calculated
thresholds (11) of severe absolute AVC and AVCdensity
were assessed by the McNemar test.
The effect of clinical, Doppler echocardiographic,
and MDCT variables on overall survival under
medical treatment was assessed using the Cox pro-
portional hazards model. Clinically relevant vari-
ables and/or variables with a p value of #0.05 on
individual analysis were included in background
multivariate models (i.e., age, sex, heart failure
[HF] symptoms, diabetes, history of coronary artery
disease [CAD], AVAi, MG, and LV ejection fraction).
For each endpoint, MG was replaced by peak
aortic jet velocity in secondary models to assess
whether this substitution affects the association of
AVC and survival. For subgroup analysis, stepwise
backward methods from general models were used.
To analyze the secondary endpoints, AVI was
used as a time-dependent covariate in the Cox
models. Results of the Cox models are presented as
hazard ratios (HRs) and 95% conﬁdence intervals
(CIs).
To determine whether severe AVCdensity offered
value in predicting 1-year mortality under medical
treatment (primary endpoint) beyond traditional risk
factors, the incremental value of severe AVCdensity
was assessed using the net reclassiﬁcation index
(NRI). Logistic regression was used to determine
predicted probabilities for 1-year all-cause mortality
under medical management in each patient, using the
background model. The probabilities were then
ranked and categorized into tertiles (<4%, 4%
to <15%, and $15%). After severe AVCdensity was
added into the model, patients were reclassiﬁed
according to the predicted probability of death at
1 year. The NRI quantiﬁed the net improvement in
risk reclassiﬁcation (higher predicted probability of
death in 1-year nonsurvivors; lower predicted proba-
bility of death in 1-year survivors). A p value #0.05
was considered statistically signiﬁcant. Statistical
analyses were performed with SPSS 20.0 software
(SPSS Inc., Chicago, Illinois).RESULTS
BASELINE CHARACTERISTICS. The baseline charac-
teristics of the 794 patients included in this study
(Mayo Clinic: 535; IUCPQ: 137; Bichat Hospital: 122)
are presented in Table 1. On stratiﬁcation of patients
by AVCdensity, patients with severe AVCdensity were
older (p < 0.0001), but comorbid clinical conditions
were within ranges similar to those in patients with
nonsevere AVCdensity. As expected, patients with
severe AVCdensity had more severe AS and presented
more often with symptoms (Table 1).
PATTERN OF MORTALITY ACCORDING TO AVC LOAD.
During the mean follow-up of 3.1  2.6 years, there
were 440 AVIs and 194 deaths. Overall 5-year survival
after diagnosis was 65  3% under medical manage-
ment and 68  2% with medical and/or surgical
management for the entire cohort. The quantitative
links between the levels of AVC load expressed
as continuous variables (absolute AVC load and
AVCdensity) and survival after diagnosis were analyzed
separately in men and women due to the differential
calciﬁcation between sexes previously reported (10).
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1206Thus, on univariate Cox proportional hazards anal-
ysis, both absolute AVC and AVCdensity were strong
predictors of mortality in men as well as in women
(all, p < 0.0001). The pattern linking AVC severity and
mortality was analyzed in spline curves (of relative
risk [RR] on the y-axis vs. AVC severity on the x-axis),
whereby a RR of 1 represents the cohort’s mean risk.
These spline curves (for absolute AVC and AVCdensity
in men and women) are presented in Figure 1 and
show clearly the high risk associated with a high
AVC load.
Furthermore, speciﬁc patterns of association be-
tween AVC load and mortality risk are noteworthy.
First, in terms of thresholds of risk, as shown in
Figures 1A and 1B, absolute AVC negatively impacted100
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FIGURE 2 Effects of AVC Burden on Survival in Patients With
AS Under Medical Treatment
Kaplan-Meier curves of survival, according to the presence
(solid red line) or absence (dashed blue line) of severe absolute
AVC ($1,274 AU in women and $2065 AU in men) (A), and the
presence (dashed blue line) or absence (solid red line) of severe
AVCdensity ($292 AU/cm
2 in women and $476 AU/cm2 in men)
(B). Note the considerable excess mortality associated with
severe calciﬁcation load. Adjusted for age, sex, New York
Heart Association functional class $III, diabetes, coronary artery
disease, aortic valve area indexed to body surface area (AVAi),
mean gradient (MG), and left ventricular (LV) ejection fraction.
Abbreviations as in Figure 1.survival under medical management, with thresholds
(crossing of the RR line of 1.0) of 1,180 AU in women
and 2,050 AU in men. These thresholds are not
different from those previously deﬁned as associa-
ted with hemodynamic markers of severe AS (both,
p > 0.12). Similarly, Figures 1C and 1D illustrate that
AVCdensity negatively impacts survival, with thresh-
olds of 300 AU/cm2 in women and 475 AU/cm2 in
men, not different from those previously deﬁned as
associated with hemodynamic markers of severe AS
(both, p > 0.24).
Second, the links between absolute AVC and
AVCdensity and mortality shown in Figure 1 were not
linear and reached a plateau. To document this
pattern, we analyzed data from patients with abso-
lute AVC and AVCdensity higher than the thresholds
of risk and categorized them as having absolute
AVC and AVCdensity higher (highly severe) and lower
(simply severe) than the medians in this high-risk
subset. In this analysis, patients with highly severe
and simply severe absolute AVC showed similar
mortality under medical management of AS (p ¼ 0.36).
Similarly, patients with highly severe versus simply
severe AVCdensity incurred similar mortality (p ¼ 0.21).
In view of this pattern of threshold and plateau
regarding the links between AVC load (both absolute
AVC and AVCdensity) and mortality after diagnosis in
men and women, subsequent analyses categorized
patients as having high versus low AVC load (with
speciﬁc thresholds in men and women), which
allowed for a combined analysis of survival in men
and women together. The Kaplan-Meier survival
curves according to the presence or absence of severe
absolute AVC and AVCdensity show that irrespective
of the measure used, patients with high AVC load
had lower survival (all p <0.0001) under medical
management (Figure 2) or with medical/surgical
management (Figure 3).
INCREMENTAL PROGNOSTIC VALUE OF SEVERE
AVC ON MORTALITY IN MEDICALLY MANAGED
PATIENTS. During a mean follow-up of 1.7  2.0 years
under medical treatment, there were 115 deaths; 82
were considered cardiovascular related. In view of
the association of higher AVC load with somewhat
older age and deﬁnitely tighter AS (Table 1), it is
essential to determine the incremental nature of the
association of AVC load with survival. On adjustment
for age, sex, HF symptoms, diabetes, CAD, AVAi, MG,
and LV ejection fraction, severe absolute AVC
(HR: 1.75; 95% CI: 1.04 to 2.92; p ¼ 0.03) and severe
AVCdensity (HR: 2.44; 95% CI: 1.37 to 4.37; p ¼ 0.002)
predicted mortality under medical management
(Table 2).
TABLE 2 Effects of Severe Absolute AVC and Severe AVCdensity on Survival:
Univariate and Multivariate Analyses
Severe Absolute AVC* Severe AVCdensity†
HR (95% CI) p Value HR (95% CI) p Value
Overall survival with medical
treatment, all patients
(N ¼ 794)
Univariate 5.63 (3.82–8.46) <0.0001 7.06 (4.66–11.02) <0.0001
Multivariate‡ 1.75 (1.04–2.92) 0.03 2.44 (1.37–4.37) 0.002
Overall survival with medical/
surgical treatment
All patients (N ¼ 794)
Univariate 3.04 (2.20–4.19) <0.0001 3.76 (2.58–5.22) <0.0001
Multivariate‡§ 1.71 (1.12–2.62) 0.01 2.22 (1.40–3.52) 0.001
Subgroup with coronary
calcium scoring (n ¼ 635),
multivariate‡§k
1.58 (1.02–2.47) 0.04 1.89 (1.14–3.09) 0.01
*Deﬁned as$1,274 AU in women and$2,065 AU in men. †Deﬁned as$292 AU/cm2 in women and$476 AU/cm2
in men. ‡Adjusted for age, sex, New York Heart Association functional class $III, diabetes, coronary artery
disease, AVAi, MG, and LV ejection fraction. §Further adjusted for aortic valve implantation as a time-dependent
variable. kFurther adjusted for severe coronary artery calciﬁcation.
HR ¼ hazard ratio; MG ¼ mean gradient; other abbreviations as in Table 1.
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1207When absolute AVA replaced AVAi in multivariate
models, the predictive values of absolute AVC (HR:
1.71; 95% CI: 1.05 to 2.84; p ¼ 0.03) and AVCdensity
(HR: 2.21; 95% CI: 1.26 to 3.98; p ¼ 0.005) were
unaffected. Replacing Vmax with MG in multivariate
models did not affect the predictive value of absolute
AVC (HR: 1.71; 95% CI: 1.02 to 2.90; p ¼ 0.04)
or AVCdensity (HR: 2.31; 95% CI: 1.30 to 4.21;
p ¼ 0.004). Similarly, AVC and AVCdensity also pre-
dicted cardiovascular-related death (HR: 2.14 [95%
CI: 1.08 to 4.45; p ¼ 0.03] and 2.28 [95% CI: 1.11 to
4.95; p ¼ 0.02], respectively). Moreover, after further
adjustment for severe coronary artery calciﬁcation,
severe AVCdensity remained predictive of mortality
(HR: 2.41; 95% CI: 1.22 to 4.77; p ¼ 0.01).
In all models, severe AVC (p # 0.04) and severe
AVCdensity (p # 0.02) provided signiﬁcant additive
value (incremental to all clinical and Doppler echo-
cardiographic variables) to the prediction of mortality
under medical treatment in AS. After adding severe
AVCdensity to the background model, the NRI in
predicting 1-year mortality was 12.5% (p ¼ 0.04).
Interestingly, the most important reclassiﬁcation was
achieved among nonsurvivors at 1 year, with a
reclassiﬁcation of 50% of these patients from the
intermediate risk to the higher-risk category (data not
shown).
On comparison of multivariate models, those using
AVCdensity were more powerful than were those uti-
lizing absolute AVC in predicting mortality under
medical treatment (all, p < 0.03). In the analysis
of the prognostic impact of AVC in subgroups strati-
ﬁed by AS severity (guideline-based thresholds),
AVCdensity was predictive of mortality under medical
management in patients with severe AS (HR: 3.11;
95% CI: 1.64 to 6.70; p ¼ 0.0002) or without severe AS
(HR: 5.69; 95% CI: 2.89 to 11.03; p < 0.0001) (Figure 4).
After adjustment for age and sex, AVCdensity remained
signiﬁcantly predictive of mortality in both groups
(HR: 2.08 [95% CI: 1.07 to 4.53; p ¼ 0.02] and 3.35
[95% CI: 1.60 to 6.85; p ¼ 0.002] in patients with and
without severe AS, respectively). With comprehen-
sive adjustment, AVCdensity came out as indepen-
dently predictive of mortality under medical
management in patients with severe AS (HR: 2.79;
95% CI: 1.45 to 5.36; p ¼ 0.002) and without severe
AS (HR: 2.93; 95% CI: 1.35 to 6.19; p ¼ 0.008)
(Figures 4 and 5).
The impact of severe AVCdensity was consistent
across multiple AS subsets: It was predictive of mor-
tality under medical treatment in women as well as
men (both, adjusted p # 0.04), in patients with and
without HF symptoms (both, adjusted p # 0.03), in
patients with MG higher or lower than 40 mm Hg(both, adjusted p # 0.04), and in patients with
AVAi higher or lower than 0.6 cm2/m2 (both, ad-
justed p # 0.02). Thus, despite stratiﬁcation causing
smaller subsets and wider CIs, high AVCdensity was
independently associated with excess mortality after
diagnosis in all subsets (Figure 5). Finally, in a com-
bined subgroup with $1 criterion for severe AS (by
AVA, AVAi, MG, or Vmax) and without HF symptoms
(n ¼ 308), AVCdensity was independently associated
with excess mortality (HR: 2.59; 95% CI: 1.02 to 8.01;
p ¼ 0.04).
IMPACT OF SEVERE AVC ON MORTALITY WITH
MEDICAL/SURGICAL TREATMENT. On analysis of
overall mortality and cardiovascular-related mortal-
ity (138 deaths) during the entire follow-up, severe
AVC (all, HR: $1.58; p # 0.04) and severe AVCdensity
(all, HR: $1.89; p # 0.01) were each independent
predictors of overall mortality (Table 2, Figure 3) and
cardiovascular-related mortality, and signiﬁcantly
improved multivariate models (all, p # 0.01), with
or without adjustment for severe coronary artery
calciﬁcation. AVCdensity demonstrated superiority (all,
p < 0.04) beyond absolute AVC for predicting overall
mortality.
Analysis of AVI beneﬁt (time-dependent variable)
in strata of AVC load showed that AVI was a powerful
independent predictor of improved survival in
patients with severe AVCdensity (HR: 0.37; 95% CI: 0.25
to 0.56; p < 0.0001), whereas AVI effect did not reach
statistical signiﬁcance in the stratum with nonsevere
AVCdensity (HR: 0.63; 95% CI: 0.25 to 1.61; p ¼ 0.33).
Thus, in patients with severe AVCdensity, AVI was
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FIGURE 3 Overall Survival, by AVC Burden, in Patients With AS
Kaplan-Meier curves of overall survival according to the presence (dashed blue line) or
absence (solid red line) of severe absolute AVC ($1,274 AU in women and $2,065 AU in
men) (A), and the presence (dashed blue line) or absence (solid red line) of severe
AVCdensity ($292 AU/cm
2 in women and $476 AU/cm2 in men) (B). Curves include post-
operative survival. Note the considerable excess mortality associated with severe calciﬁ-
cation load, supporting the analysis in patients under medical management. Adjusted for
age, sex, New York Heart Association functional class $III, diabetes, coronary artery dis-
ease, AVAi, MG, LV ejection fraction, and aortic valve implantation as a time-dependent
variable. Abbreviations as in Figures 1 and 2.
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1208associated with considerable alleviation of mortality
risk, conﬁrming that the AVCdensity–survival link
directly depends on the AS.
DISCUSSION
This study, conducted on the basis of a large inter-
national registry of calciﬁed aortic valve disease, is
the ﬁrst to show that in a pure population of patients
with AS, AVC load, as measured by MDCT, indepen-
dently predicts mortality after AS diagnosis, with
or without regard to treatment (Central Illustration).
This strong impact on mortality persists even
after adjustment for hemodynamic characteristics,including AVAi and MG (or alternatively AVA and
Vmax), and even accounting for clinical history of
CAD or MDCT-measured coronary artery calciﬁca-
tion. The AVC–mortality link is incremental in all
clinical and Doppler echocardiographic measures
with a notable NRI and persists in patients with
hemodynamically severe AS. The pattern of the
AVC–mortality link involves thresholds similar to
those deﬁning severe aortic valve disease in com-
parison to hemodynamic data by Doppler echocar-
diography for both absolute AVC and AVCdensity (11),
followed by a plateau of risk. Thus, whereas the
thresholds deﬁning severe AVC are different in men
and women, the presence of severe AVC deﬁned by
these thresholds holds similar survival implications
in both sexes. Furthermore, AVCdensity indexed to
cross-sectional area of aortic annulus was a more
powerful survival predictor than was absolute AVC,
and its impact was consistent among all subsets of
AS, irrespective of initial presentation. Finally, sur-
vival was improved by AVI in patients with severe
AVCdensity, emphasizing the direct link between the
valvular anatomic alteration and its implications
on outcome.
AVC IN AS. In the general population, there is
growing evidence that calciﬁed aortic valve disease
is prognostically signiﬁcant (8,9), but AS is naturally
calciﬁed, so the signiﬁcance of calciﬁcations within
that speciﬁc valvular condition remains uncertain.
In current U.S. clinical guidelines (1), severe or
moderate-severe AVC is mentioned as a parameter to
be considered in AS management, although there are
no recommendations on speciﬁc deﬁnitions or im-
plications. This recommendation is made on the basis
of echocardiographic data regarding AS progression
(18) and cardiovascular events (12). However, cal-
ciﬁcation by echocardiography is diagnosed on the
basis of video qualitative assessment, which grossly
correlates with AVC quantiﬁed by CT but with
wide overlap between echo “calciﬁcation” grades
(7). The imprecise aortic valve “calcium” scoring on
echocardiography has not allowed for the detection of
crucial differences between men and women; MDCT,
taking advantage of the unequaled value of x-ray
calcium assessment, provided deﬁnitions of severe
AVC load speciﬁc to men and women, with lower
thresholds in women (10,11). Thus, this imprecise
echo evaluation of valvular “density” has not been
duplicated in terms of outcome and has not been re-
ported as a crucial measure to be performed in pa-
tients with AS (1,2). The present study, by using the
hard endpoint of survival and quantitative assess-
ment of valvular calcium by MDCT, extends our
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FIGURE 4 Effects of AVC Burden on Survival in Patients With
AS Under Medical Treatment, Stratiﬁed by Severity of AS
on Hemodynamic Assessment
Kaplan-Meier curves of survival, according to AVC burden, in
patients with nonsevere (A) and severe (B) aortic stenosis (AS),
as evaluated by guideline criteria (1). Severe AS is deﬁne by an
MG $40 mm Hg, Vmax $4 m/s, or AVA #1 cm
2. In both strata of
severity of AS on hemodynamic assessment, severe AVCdensity
($292 AU/cm2 in women and$476 AU/cm2 in men) is associated
with lower survival. Both unadjusted and adjusted p values for
the comparison of the presence (dashed blue lines) versus the
absence (solid red lines) of severe AVCdensity are presented for
each stratum. Adjusted using stepwise backward Cox analysis.
Abbreviations as in Figures 1 and 2.
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1209ﬁndings regarding the hemodynamic signiﬁcance of
AVC load in men and women, showing that even after
normalization for aortic annulus cross-sectional area,
the impact on mortality occurs at lower scores in
women compared with men. Thus, deﬁning severe
AVC as absolute AVC $1,274 AU in women and $2,065
AU in men or as AVCdensity $292 AU/cm2 in women
and $476 AU/cm2 in men not only strongly suggests
severe hemodynamic AS (11) but also deﬁnes severe
calciﬁed aortic valve disease for subsequent mortal-
ity. Previous studies with CT, including our pilot
study of 2004 (7), linked valve calciﬁcation to car-
diovascular events following diagnosis, dominated by
performance of AVI, and the pitfalls of this endpoint
may explain why this measure has not yet gained
wide acceptance. Furthermore, different thresholdswere used (16,18), no sex-speciﬁc threshold was
deﬁned, and due to the strong association between
AVC and valve hemodynamic data, the incremental
value of AVC remained unclear. The present study
is thus the ﬁrst to link AVC load, objectively and
quantitatively measured, to the simple and crucially
important outcome of mortality. Hence, we believe
that such an observation is essential in emphasizing
the importance of AVC load measurement in clinical
practice and in recommending speciﬁc thresholds.
MDCT measurement of AVC load represents a
test added to classic Doppler echocardiography,
but demonstration of its incremental prognostic in-
formation is essential vis-à-vis cost, whereas it is
routine before transcatheter AVI (19).
The concept that AVC load provides information
incremental in hemodynamic measures of AS severity
is not completely intuitive, as the hemodynamic load
is considered the ultimate cause of death (20). How-
ever, AVC, although long known to be present on the
valve and considered a scarring phenomenon (21), has
been shown to appear early in valve lesions as an
integral part of the disease process (22). Furthermore,
calciﬁcation is a nonlinear process that increases
exponentially (23) and accelerates disease progres-
sion (24). With this in mind, we see that the impli-
cations of AVC load on survival do not represent a
statistical artefact but are coherent with the biology
of AVC deposition (25). It is thus logical, from a
pathophysiological standpoint, that a severe amount
of calcium in the aortic valve will lead to faster
disease progression (23), adverse events, and ulti-
mately mortality. The initial low mortality in mod-
erate AS, even with severe AVC, is consistent with
previous data on AS outcome (6), but over time
severe AVC imposes excess mortality in all AS
severity grades. As shown in our study, survival
was largely improved by AVI selectively in patients
with severe AVC, underscoring the coherent bio-
logical and outcome rationale of AVC load as a
marker of AS outcome.
AVC AND AS MANAGEMENT. In view of its implica-
tions on diagnosis and survival, AVC load can be
used as an objective marker of severity in patients in
whom clinical assessment is confusing. Given that
AS today typically results from calciﬁc “degenera-
tive” etiology and is diagnosed in the mid-seventh
decade (6), it is commonly associated with symp-
toms or markedly reduced activity. Concomitant
comorbidities also may cause symptoms, making a
patient’s risk quite difﬁcult to interpret. In this
challenging clinical context, objective markers of
outcome are crucial in stratifying risk at diagnosis
3.64 (1.49-9.77); p=0.004
2.03 (1.04-4.08); p=0.04
2.87 (1.30-6.55); p=0.009
2.50 (1.07-6.27); p=0.03
2.79 (1.45-5.36); p=0.002
2.93 (1.35-6.19); p=0.008
1.82 (1.03-3.21); p=0.04
6.81 (1.39-123.11); p=0.01
1.98 (1.09-3.93); p=0.02
3.07 (1.29-7.10); p=0.01
2.29 (1.03-5.86); p=0.04
3.02 (1.60-5.71); p=0.001
p=0.07
p=0.18
p=0.85
p≥0.19
0.5 1 2 3 4 5 6 8 10 130
Hazard Ratio of AVCdensity
(Under Conservative Management)
Relative risk
(95%CI)
P-value for
Interaction
GENDER
SYMPTOMS
AS SEVERITY
LV FUNCTION
Women
Men
NYHA I-II
NYHA III-IV
Severe AS
Non Severe AS
Mean Gradient<40mmHg
Mean Gradient≥40mmHg
Indexed Aortic Valve Area≤0.6cm2/m2
Indexed Aortic Valve Area>0.6cm2/m2
LV Ejection Fraction<50%
LV Ejection Fraction≥50%
FIGURE 5 Comprehensive Subgroup Analysis of Mortality in Patients With AS Under Medical Treatment
Mortality in patients with AS under medical treatment, according to the presence of severe AVCdensity ($292 AU/cm
2 in women
and $476 AU/cm2 in men). In each subgroup, the adjusted hazard ratio and 95% conﬁdence intervals (CIs) are presented, using stepwise
backward Cox analysis. LV ¼ left ventricular; NYHA ¼ New York Heart Association functional class; other abbreviations as in Figure 1.
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1210and for this AVC load may play a very important role
once its link to survival is ascertained. Speciﬁcally,
measuring AVC load by MDCT may be crucial in pa-
tients with discordant Doppler echocardiographic
markers of AS severity.
Indeed, between 30% and 70% of patients diag-
nosed with AS present with low MG despite tight
AVA (6,26,27). This hemodynamic presentation is
highly heterogeneous with or without low ﬂow, often
with preserved ejection fraction, and stems from
possible measurement errors (28), asymmetry of the
LV outﬂow tract (29), and/or decreased systemic
arterial compliance (30). Irrespective of the reason,
this hemodynamic presentation proves challenging in
terms of diagnosis and therapeutic decision making.
Tight AVA suggests severe AS and favors AVI,
whereas low gradient is rather consistent with mod-
erate stenosis and favors conservative management.
Although in patients with low ejection fraction,
dobutamine echocardiography is valuable to detect
pseudosevere AS (31–33), it is unclear how useful the
test is in patients with preserved ejection fraction
and low ﬂow and its utility is even less likely in pa-
tients with normal ﬂow (34–37). In the context of the
uncertainty of hemodynamic status, obtaining an
independent and direct measure of aortic valvelesion severity such as AVC load is crucial. Uncer-
tainty with regard to clinical status is no less
frequent than is that of hemodynamic status. A trial
of percutaneous treatment of AS demonstrated great
beneﬁt but also showed that AS treatment may be
futile when comorbidity blurs symptom interpreta-
tion (38). This frequent clinical situation, and that
regarding the decision of whether moderate AS de-
serves AVI simultaneously with coronary artery
bypass surgery (1), represent conundrums in which
the independent evaluation of aortic valve disease is
crucial. In addition to its diagnostic value, severe
AVC load, independently and incrementally linked to
lower survival alleviated by AVI, as measured by
MDCT may be an essential candidate “tie-breaker”
and indicator of follow-up frequency when AVI is
delayed. The prognostic impact of AVC in various AS
subsets (i.e., reduced or preserved ejection fraction,
with low or high MG or AVA) makes AVC a versatile
clinical tool in most situations warranting the
consideration of AVI.
STUDY LIMITATIONS. MDCT measurements were
done in each institution, and this international
collaboration was challenging in terms of exchanging
images among centers. However, the training for
CENTRAL ILLUSTRATION AVC: Measurement, Thresholds, and Impact on Survival
(Top left images) AVC on a thoracic slice on computed tomography (CT). The tables
(top right panels) and spline curve analysis (middle panel) demonstrate that the
thresholds used to deﬁne severe AS and its impact on survival are different in women
and men. The spline curve (solid line) is presented with 95% conﬁdence interval
(dotted lines). The red zone represents the range of AVCdensity corresponding to the
95% bracket of the spline curve when it crosses the line at relative risk (RR) ¼ 1.
(Lower panel) Kaplan-Meier curves show the impact of AVC burden on survival in
patients with AS. HR ¼ hazard ratio (95% conﬁdence interval). *Adjusted for age, sex,
New York Heart Association functional class $III, diabetes, coronary artery disease,
AVAi, MG, LV ejection fraction, and aortic valve implantation as a time-dependent
variable.
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1211calcium measurement was common and standardized
in the 3 centers, and we arranged intercenter
investigators’ visits to address interobserver vari-
ability (10). The possibility of a “center effect” on the
AVC–mortality link was unlikely, with no interaction
between centers and AVC in determining all-cause or
cardiovascular mortality (all, p > 0.80). The thresh-
olds deﬁning severe AVCdensity may not have been
easy to remember in clinical practice. Simple rounded
thresholds of 300 AU/cm2 in women and 500 AU/cm2
in men may be considered in clinical practice.
Although not exactly data deﬁned, hemodynamic
based, or outcomes based, these rounded thresholds
of severe AVC load provided prediction of mortality
under medical management that was not signiﬁ-
cantly inferior to that of data-deﬁned thresholds
(p ¼ 0.36).
AVC may have different levels of additive predic-
tion value in different AS subsets (e.g., discordant,
low-gradient AS), but studies in larger sample sizes
should be planned in the future for all AS subset
analyses.
CLINICAL IMPLICATIONS. In the elderly AS popula-
tion, whose lack of symptoms may be related to
inactivity or orthopedic ailments, or whose symp-
toms may be due to comorbid conditions, gathering
objective outcomes markers is essential. AVC as
measured by MDCT is low risk, noninvasive, and
highly reproducible for that purpose in most patient
subsets. MDCT is not indispensable in patients with
an obvious surgical indication of AVI but is essential
in considering transcatheter AVI. In patients with
borderline indications, particularly with doubtful
hemodynamic data, severe AVC load may be a crucial
element of a difﬁcult decision. When the indication
of an intervention is clearly not present, AVC load
may inﬂuence the frequency of follow-up. The
pattern of the impact of AVC on mortality showed
distinctly that once the threshold is reached, the
risk for death increases. This threshold is different
and lower in women compared with that in men,
even after adjustment for aortic annulus area. Thus,
patients with an AVCdensity $300 AU/cm2 (women) or
$500 AU/cm2 (men) should be considered as having
severe AS and treated accordingly, whereas those
with lower amounts of calciﬁcation should be
considered as having moderate AS and followed
closely as the level of calciﬁcation approaches the
threshold.
CONCLUSIONS
This large-scale, international outcomes study shows
that measuring AVC load by MDCT provides importantincremental prognostic value for survival after AS
diagnosis beyond that obtained from clinical and
Doppler echocardiographic data. Severe AVCdensity,
although deﬁned differently in men and women,
holds similar independent prognostic value in both
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The
extent of aortic valve calciﬁcation correlates with the
hemodynamic severity of aortic stenosis.
TRANSLATIONAL OUTLOOK: Additional studies
are needed to quantify the incremental value of MDCT
over echocardiographic and hemodynamic assess-
ments in selecting symptomatic patients with aortic
stenosis for valve replacement when the valve oriﬁce
area and pressure gradient are discordant.
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1212sexes and in all possible AS subsets. The excess
mortality associated with severe AVCdensity is greatly
alleviated by AVI. Thus, the measurement of AVC
by MDCT should be considered for not only diagno-
stic but also risk-stratiﬁcation purposes in the evalu-
ation of and therapeutic decision making in patients
with AS.
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